Home › Cervical Cancer › Oklahoma › Tulsa
Cervical Cancer clinical trials in Tulsa, OK
4 studies for Cervical Cancer are looking for participants at sites in and around Tulsa (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
RecruitingPhase 1/2
- Oklahoma Cancer Specialists and Research Institute, LLC, Tulsa
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
RecruitingPhase 3
- Oklahoma Cancer Specialists and Research Institute, LLC ( Site 6001), Tulsa
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
RecruitingPhase 4
- Oklahoma Cancer Specialists and Research Institute, LLC, Tulsa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Tulsa
About Cervical Cancer
Cervical cancer starts in the cells of the cervix, which is the lower, narrow end of the uterus. Long-lasting HPV infection causes almost all cervical cancers.
More about Cervical Cancer on MedlinePlus
Cervical Cancer trials in other cities
- Houston, TX34 studies
- New York City, NY20 studies
- Nashville, TN19 studies
- Boston, MA19 studies
- Arlington, VA18 studies
- Los Angeles, CA17 studies
- San Antonio, TX14 studies
- Dallas, TX14 studies
- St. Louis, MO12 studies
- Orlando, FL12 studies
- Columbus, OH12 studies
- Baldwin Park, CA11 studies
Other studies in Tulsa
- Heart Failure13 studies
- Overweight6 studies
- COPD5 studies
- Ischemic Stroke5 studies
- Obesity5 studies
- Cardiovascular Disease5 studies
- Melanoma5 studies
- Parkinson's Disease4 studies
- Ovarian Cancer4 studies
- Aortic Valve Stenosis4 studies
- Heart Diseases4 studies
- Non-Small Cell Lung Cancer4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.